4basebio PLC's receivables is $290K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2025), 4BB.L shows a receivables of $290K. That compares with $280K in the prior-year period — up 2.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4BB.L's receivables is now $290K (was $280K) — a 2.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 4basebio PLC is outperforming or lagging.
Tracking 4BB.L's receivables over time shows whether 4basebio PLC is scaling, shrinking, or reshaping that part of the business. The current reading is $290K That compares with $280K in the prior-year period — up 2.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has 4basebio PLC's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $290K) with ownership activity and broader fundamentals.
4basebio PLC's receivables is $290K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.